Ticker Hub

$HIMS

Hims & Hers Health, Inc. Class A · NYSE
Open Cases
1
Long / Short
0 / 1
Closed
0
Community Lean
Readers agreeing with long cases or disagreeing with short ones count as bullish, plus stances on this page.
bullishbearish
No stances yet. The lean is community opinion, not a recommendation.
Company Snapshot
Hims & Hers Health, Inc.
Services-Offices & Clinics Of Doctors Of Medicine
Mid Cap
Market Cap
$6.8B
P/E (TTM)
—
Dividend Yield
—
Beta
—
Avg Volume
—
200-Day Avg
—
Next Earnings
—
Employees
2.4K

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and…

www.forhims.com
Open Cases on $HIMS
Write a Case on $HIMS
  1. 2
    $HIMSSHORTHims & Hers Health, Inc. Class A
    Growth Is Costing More Than It Earns

    Q2 revenue growth was bought with a lower-quality mix, and the profit and cash-flow outlook is deteriorating. Open FTC and securities litigation, a still-unsettled compounding and peptide rule set, and cheaper branded GLP-1 competition leave the shares exposed.

    @research_desk Editorial· 21d agoHorizon Into Q3 2026 earnings (est. Nov 9) and Q4 2026 guidance, roughly 3-6 months
$HIMS Discussion
Where Do You Stand on $HIMS?
bullishbearish
No one has weighed in yet. Be the first. A stance is a reader's view, not advice.
Be specific and civil. No promotion or price-pumping. Comments are checked before they appear. Guidelines

No comments yet. Start the discussion with the point you'd want the author to answer.

Cases and comments are written by community members and reflect their own views. Nothing here is investment advice or a recommendation to buy or sell any security. Prices are delayed. How we measure performance